quantum computing Archives - Medical Design Sourcing

Denmark teams up with Novo Nordisk Foundation, NVIDIA to launch visionary AI research center

A total of 15,128 NVIDIA H100 Tensor Core GPUs (pictured here) will be used in the Denmark AI Innovation Center. The hardware can support the development of advanced AI applications, from protein structure prediction to quantum computing research.

A collaboration between the Novo Nordisk Foundation, the Export and Investment Fund of Denmark (EIFO), and NVIDIA will establish a national AI Innovation Centre in Denmark focused on accelerating research and innovation in fields including healthcare, life science, and quantum computing. The initiative is led on the Danish side by the Novo Nordisk Foundation, which has committed roughly DKK 600 million (around $90 million) toward the initial costs of the center, and the Export and Investment Fund of Denmark (EIFO), which has contributed another DKK 100 million.

In a press briefing, Kimberly Powell, NVIDIA’s VP of healthcare, highlighted Denmark’s “…

Microsoft and 1910 Genetics: AI-powered partnership targets billion-dollar savings and growth in drug discovery

[Image: 1910 Genetics]

The pharmaceutical industry is at a critical juncture: AI and other technological advances offer unprecedented potential, yet the cost of developing new drugs has ballooned for decades, surpassing $2 billion in recent years with the projected return on investment (ROI) falling to a mere 1.2% in 2022, according to Deloitte. Another dimension of the problem is the high failure rate — many potential drugs fall short in the expensive clinical trials.

Microsoft and 1910 Genetics have announced a partnership that aims to reverse the troubling trend.

Accelerating discovery with AI and quantum-inspired computing

Microsoft’s Azure Quantum Elements is at the core of this alliance. The platform integrates high-performance computing, AI, and quantum techniques for faster scientific discovery in chemistry and materials science. The goal is to democratize technologies like AI, high-performa…

Quantum leaps in drug discovery? NobleAI joins forces with Microsoft while King’s College London aligns with Kvantify

[Production Perig/Adobe Stock]

The word “revolutionize” gets thrown around a lot in describing the potential of emerging technologies. But quantum computing could make good on the promise to disrupt healthcare applications ranging from drug discovery to medical imaging. Theoretically, a quantum computer with 300 quantum bits (qubits) could crunch more calculations in an instant than there are atoms in the visible universe. Because qubits can exist in multiple states at once, quantum computers can bring powerful parallel processing to fields where exploring a vast solution space is required, including drug discovery and material science.

It’s no wonder that the computing branch, which remains in its infancy, is attracting a growing amount of attention as it inches towards practical applicability. In May, Insilico Medicine said it was exploring the use of quantum computing and generative AI to help ide…

Microsoft details how its technology is advancing drug discovery and biomedical research

[Adobe Stock/max_776]

As cloud technology matures, life-sciences companies are finding new avenues for business value in life sciences, extending beyond the cost efficiencies typically associated with cloud migrations, as McKinsey noted. In an email statement, Microsoft outlined how its own cloud computing, AI and research capabilities are driving similar innovation for biopharma companies. This article explores Microsoft Research initiatives related to drug discovery, including technology developments and strategic collaborations.

Quantum Computing’s role in Microsoft Research’s drug discovery and scientific research push

A key facet of Microsoft Research’s impact on drug discovery lies in its quantum computing initiatives. In terms of quantum computing efforts, the company said, “We’d like to first share with you our recent announcement on new advances to Azure Quantum, aimed at accelerating …

Microsoft goes all in on Azure Quantum to accelerate scientific discovery

[Peter Jurik/Adobe Stock]

In the rapidly evolving landscape of quantum computing, Microsoft is pushing the boundaries with its Azure Quantum platform. As Microsoft CEO Satya Nadella recently announced, “Our goal is to compress the next 250 years of chemistry and material science progress into the next 25,” Nadella said. The executive also noted that, thanks to recent advances in quantum computing, “we’re closer than ever to the promise of a scalable quantum machine capable of solving some of the world’s most intractable problems.”

To accelerate this vision, Microsoft’s Azure Quantum introduces capabilities to expedite scientific discovery. Azure Quantum Elements merges high-performance computing, AI and quantum computing on Microsoft Azure. This combination accelerates quantum chemistry simulations and widens the search space for new materials. Azure Quantum Elements taps AI models traine…

Quantum computing promises new frontier in drug discovery and bioinformatics

[James Thew/Adobe Stock]

Quantum computing — described by pop astrophysicist Neil deGrasse Tyson as “computing with atoms” — is an emerging technology with a potential for immense computational speed and power. For some problems, quantum computers can be exponentially faster than classical computers, while for others the speedup may be more measured. The promise for drug discovery could be significant.

But the promises of quantum computing extend beyond mere increases in data processing horsepower. In an era dominated by generative AI models, which rely heavily on massive volumes of data for predictions, a different perspective emerges. Kristin M. Gilkes, EY Global Innovation Quantum Leader, underscores this shift in perspective. “I don’t believe we’ll need as much data with quantum computing,” she said. Gilkes sees the focus is shifting towards becoming data-centric, prioritizing the right set…

SandboxAQ, bearing Alphabet’s DNA, eyes quantum-inspired breakthroughs in drug discovery

[Sakkmesterke/Adobe Stock]

Emerging as a spinoff from Alphabet’s experimental division X, SandboxAQ recently pulled back the curtain on its latest endeavor — the biopharma molecular simulation division AQBioSim. Attracting investments from significant figures like former Alphabet CEO Eric Schmidt, who is now the chair of Sandbox AQ, and Salesforce.com Inc. founder Marc Benioff’s Time Ventures investment fund. Other backers include T. Rowe Price, Guggenheim Partners and Breyer Capital.

Now, AQBioSim aims to streamline the research and development process with quantum-inspired computing, potentially contributing to the development of treatments for critical diseases, such as cancer, Alzheimer’s and Parkinson’s. The company says its technology could shave years off the discovery process.

Earlier this year, SandboxAQ, raised $500 million in funding, aiming to equip businesses with the neces…